The primary reason fueling the expansion of the Dry Eye Syndrome Market is the rising prevalence of eye disorders as a result of a change in lifestyle. Additionally, the market is growing as a result of the ageing population and the rising prevalence of lifestyle disorders like diabetes, obesity, and hypertension.
There has been a significant increase in public awareness of the dry eye condition and the necessity for treatment. This, together with improvements in therapeutic methods, are projected to accelerate Dry Eye Syndrome Market expansion. Furthermore, the global market for dry eye condition is expected to benefit from rising public and private investments in the expansion of the healthcare industry.
Top Companies are AbbVie Inc., Novartis AG, Bausch Health Companies Inc., Johnson & Johnson, Inc., I-MED Pharma inc., Santen Pharmaceutical Co., Ltd, AFT Pharmaceuticals, Novaliq GmbH, Otsuka Pharmaceutical Co., Ltd., Sun Pharmaceutical Industries, Inc., Teva Pharmaceutical Industries Ltd., Mitotech, SA, Viatris Inc.
Source Link- https://cmi-latestreportorientedblogs.blogspot.com/2023/01/the-rising-prevalence-of-dry-eye-to.html
